Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 9, 2021
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
Mon, March 8, 2021
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
Patrick Trucchio Maintained (VIR) at Strong Buy with Increased Target to $135 on, Mar 8th, 2021
Patrick Trucchio of HC Wainwright & Co., Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Increased Target from $125 to $135 on, Mar 8th, 2021.
Patrick has made no other calls on VIR in the last 4 months.
There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 0 agree with Patrick's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Patrick
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $75 on, Tuesday, March 2nd, 2021
- Anupam Rama of "JP Morgan" Downgraded from Hold to Sell and Held Target at $30 on, Wednesday, January 27th, 2021
